Detalles de la búsqueda
1.
Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
Cancer
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38781433
2.
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Cancer
; 130(S8): 1524-1538, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515388
3.
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.
Cancer Immunol Immunother
; 73(8): 154, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833154
4.
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
BMC Cancer
; 24(1): 302, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443891
5.
lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
EMBO Rep
; 23(1): e53140, 2022 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779552
6.
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
Int J Cancer
; 152(4): 749-760, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121651
7.
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study.
BMC Med
; 21(1): 173, 2023 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147645
8.
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.
Invest New Drugs
; 41(6): 808-815, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37889382
9.
Sintilimab Plus Apatinib and Chemotherapy as Second/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial.
BMC Cancer
; 23(1): 211, 2023 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36872337
10.
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.
BMC Cancer
; 23(1): 422, 2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37161562
11.
Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer.
Mol Ther
; 29(9): 2723-2736, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905821
12.
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703).
Oncologist
; 26(10): e1693-e1703, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105207
13.
Gastric cancer derived exosomes mediate the delivery of circRNA to promote angiogenesis by targeting miR-29a/VEGF axis in endothelial cells.
Biochem Biophys Res Commun
; 560: 37-44, 2021 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965787
14.
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Gastric Cancer
; 24(4): 913-925, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33945049
15.
Is hand grip strength a necessary supportive index in the phenotypic criteria of the GLIM-based diagnosis of malnutrition in patients with cancer?
Support Care Cancer
; 29(7): 4001-4013, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33398429
16.
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
JAMA
; 326(10): 916-925, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34519801
17.
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 21(6): 832-842, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32416073
18.
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.
Mol Cancer
; 19(1): 43, 2020 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106859
19.
Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.
Genome Res
; 27(8): 1312-1322, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28487279
20.
Identification of HGF as a novel target of miR-15a/16/195 in gastric cancer.
Invest New Drugs
; 38(4): 922-933, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31414268